NEWLINK GENETICS CORP ((NLNK)) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 385 transactions totaling $72.7M, demonstrating a bearish sentiment with -$36.0M in net insider flow. The most recent transaction on Jan 4, 2020 involved a transaction of 281 shares valued at $621.
No significant insider buying has been recorded for (NLNK) in the recent period.
No significant insider selling has been recorded for (NLNK) in the recent period.
Based on recent SEC filings, insider sentiment for (NLNK) is bearish with an Insider Alignment Score of 25/100 and a net flow of -$36.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at NEWLINK GENETICS CORP ((NLNK)) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading (NLNK) stock, having executed 385 transactions in the past 90 days. The most active insider is Charles J. Link Jr (Executive), who has made 109 transactions totaling $28.7M.
Get notified when executives and directors at (NLNK) file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 4, 2020 | W. Langren Carl | Executive | Payment | 281 | $2.21 | $621 | |
| Jan 4, 2020 | P. Kennedy Eugene | Executive | Payment | 376 | $2.21 | $831 | |
| Jan 2, 2020 | S. Zoth Lota | Executive | Award | 2,100 | $N/A | $0 | |
| Aug 24, 2019 | J. Powers Bradley | Executive | Payment | 76 | $1.59 | $121 | |
| Jun 23, 2019 | P. Kennedy Eugene | Executive | Payment | 359 | $1.57 | $564 | |
| Jan 4, 2019 | P. Kennedy Eugene | Executive | Payment | 376 | $1.55 | $583 | |
| Jan 4, 2019 | J. Link Charles Jr | Executive | Payment | 5,906 | $1.55 | $9.2K | |
| Jan 4, 2019 | N. Vahanian Nicholas | Executive | Payment | 2,626 | $1.55 | $4.1K | |
| Jan 4, 2019 | W. Langren Carl | Executive | Payment | 398 | $1.55 | $617 | |
| Jan 2, 2019 | J. Link Charles Jr | Executive | Payment | 5,699 | $1.66 | $9.5K | |
| Jan 2, 2019 | N. Vahanian Nicholas | Executive | Payment | 2,229 | $1.66 | $3.7K | |
| Jan 2, 2019 | W. Langren Carl | Executive | Payment | 646 | $1.66 | $1.1K | |
| Dec 12, 2018 | W. Langren Carl | Executive | Option Exercise | 2,564 | $0.80 | $2.1K | |
| Dec 12, 2018 | J. Link Charles Jr | Executive | Option Exercise | 2,564 | $0.80 | $2.1K | |
| Oct 1, 2018 | B. Henneman John III | Executive | Payment | 2,484 | $2.28 | $5.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 199 | $54.4M | 69.1% |
Purchase(P) | 5 | $18.4M | 23.4% |
Exercise(M) | 73 | $2.5M | 3.2% |
Other(J) | 2 | $2.1M | 2.7% |
Payment(F) | 54 | $1.2M | 1.6% |
Award(A) | 38 | $0 | 0.0% |
Gift(G) | 14 | $0 | 0.0% |
Insider selling pressure at NEWLINK GENETICS CORP has increased, with 15 insiders executing 385 transactions across all time. Total sales of $54.4M significantly outpace purchases of $18.4M, resulting in a net outflow of $36.0M. This selling activity appears largely discretionary, which may warrant closer attention from investors.